[PDF][PDF] Inhibition of CYP1A2-mediated drug metabolism in vitro and in humans: With special emphasis on rofecoxib and other NSAIDs
M Karjalainen - 2008 - helda.helsinki.fi
CAR Constitutive androstane receptor CI Confidence interval CL Clearance Cmax Peak
concentration COX Cyclo-oxygenase CV Coefficient of variation CYP Cytochrome P450 …
concentration COX Cyclo-oxygenase CV Coefficient of variation CYP Cytochrome P450 …
[PDF][PDF] Inhibition of CYP1A2-mediated drug metabolism in vitro and in humans
M Karjalainen - helda.helsinki.fi
CAR Constitutive androstane receptor CI Confidence interval CL Clearance Cmax Peak
concentration COX Cyclo-oxygenase CV Coefficient of variation CYP Cytochrome P450 …
concentration COX Cyclo-oxygenase CV Coefficient of variation CYP Cytochrome P450 …
[引用][C] Inhibition of CYP1A2-mediated drug metabolism in vitro and in humans: with special emphasis on rofecoxib and other NSAIDs
MJ Karjalainen - 2008 - researchportal.helsinki.fi
Inhibition of CYP1A2-mediated drug metabolism in vitro and in humans: with special emphasis
on rofecoxib and other NSAIDs — University of Helsinki Skip to main navigation Skip to search …
on rofecoxib and other NSAIDs — University of Helsinki Skip to main navigation Skip to search …
Inhibition of CYP1A2-mediated drug metabolism in vitro and in humans: With special emphasis on rofecoxib and other NSAIDs
M Karjalainen - 2008 - urn.fi
The cytochrome P450 1A2 (CYP1A2) is one of the major metabolizing enzymes. The muscle
relaxant tizanidine is a selective substrate of CYP1A2, and the non-steroidal anti …
relaxant tizanidine is a selective substrate of CYP1A2, and the non-steroidal anti …